- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Taiko Pharmaceutical Co Ltd
Add to Portfolio4574:JT
611 JPY 4 0.65%As of 02:00:00 ET on 05/25/2012.
Snapshot for Taiko Pharmaceutical Co Ltd (4574)
| Open: | 616 | Day's Range: | 610 - 618 | Volume: | 12,900 | Bid: | 610 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 615 | 52wk Range: | 610 - 930 | 1-Yr Rtn: | -26.89% | Ask: | 613 |
Key Statistics for 4574
| Current P/E Ratio (ttm) | 16.3930 |
|---|---|
| Estimated P/E (03/2013) | 14.1763 |
| Earnings Per Share (JPY) (ttm) | 37.2720 |
| Est. EPS (JPY) (03/2013) | 43.1000 |
| Est. PEG Ratio | - |
| Market Cap (M JPY) | 7,947.15 |
| Shares Outstanding (M) | 13.01 |
| Enterprise Value (M JPY) (ttm) | 3,325.23 |
| Enterprise Value/EBITDA (ttm) | 4.30 |
| Price/Book (mrq) | 0.9032 |
| Price/Sale (ttm) | 1.1829 |
| Dividend Indicated Gross Yield | 1.6367 |
| Next Earnings Announcement | 08/14/2012 |
More 4574 Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for 4574
- Operating
- Investing
- Financing (M/JPY)
Company Profile & Key Executives for 4574
Taiko Pharmaceutical Co Ltd. is a pharmaceutical company that manufactures and sells gastrointestinal pharmaceuticals and general use pharmaceutical products.
| Hitoshi ShibataChairman | Takashi ShibataPresident |
| Tomosada YoshikawaManaging Director | Seiichi FukamiDirector |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page